Lv4
706 积分 2025-04-27 加入
Genotoxic Impurities: Strategies for Identification and Control
3个月前
已关闭
Second cancer incidence in CLL patients receiving BTK inhibitors
6个月前
已完结
Ibrutinib-associated dermatologic toxicities: A systematic review and meta-analysis
6个月前
已完结
Kinase-impaired BTK mutations are susceptible to clinical-stage BTK and IKZF1/3 degrader NX-2127
8个月前
已完结
Generation of TD50 values for carcinogenicity study data
10个月前
已完结
Discovery of EEDi-5273 as an Exceptionally Potent and Orally Efficacious EED Inhibitor Capable of Achieving Complete and Persistent Tumor Regression
10个月前
已完结
皖公网安备34019202002308
